Nanjing Medlander Medical Technology Co (SHSE:688273) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co Change In Receivables?

Nanjing Medlander Medical Technology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Nanjing Medlander Medical Technology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Nanjing Medlander Medical Technology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥16.4 Mil. It means Nanjing Medlander Medical Technology Co's Accounts Receivable declined by ¥16.4 Mil from Dec. 2022 to Dec. 2023 .

Nanjing Medlander Medical Technology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥18.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Nanjing Medlander Medical Technology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 16.16.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nanjing Medlander Medical Technology Co's liquidation value for the three months ended in Mar. 2024 was ¥915.3 Mil.

Nanjing Medlander Medical Technology Co Change In Receivables Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co Change In Receivables Chart

Nanjing Medlander Medical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-19.26

-1.25

2.61

-16.48

16.38

Nanjing Medlander Medical Technology Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial												-	-	-	-	-

Nanjing Medlander Medical Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Nanjing Medlander Medical Technology Co (SHSE:688273) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nanjing Medlander Medical Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	18.478	/	104.337	*	91
=	16.16

2. In Ben Graham's calculation of liquidation value, Nanjing Medlander Medical Technology Co's accounts receivable are only considered to be worth 75% of book value:

Nanjing Medlander Medical Technology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1024.784	-	148.42	+	0.75 * 18.478	+	0.5 * 50.146
=	915.3

Nanjing Medlander Medical Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Nanjing Medlander Medical Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Medlander Medical Technology Co (SHSE:688273) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100

Website

http://www.medlander.com

Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.

Executives

Zhu Bi Sheng	senior management
Chen Jiang Ning	senior management
Yang Rui Jia	Directors, senior managers, core technical personn
Shi Zhi Huai	Directors, senior managers, core technical personn
Chen Bin	Directors, senior managers
Tu Hong Lin	Directors, senior managers
Wang Wang	senior management

Nanjing Medlander Medical Technology Co (SHSE:688273) Headlines

No Headlines